Who should not take Humanin?
Documented caution flags for Humanin include pregnancy / nursing and no data in active malignancy. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Humanin is limited.
Documented caution flags for Humanin
- Pregnancy / nursing
- No data in active malignancy
Reported side effects to weigh
- Generally well tolerated
- Limited safety data, short cycles preferred
References
- Humanin: a harbinger of mitochondrial-derived peptides — Lee C et al., Trends Endocrinol Metab, 2013
- Humanin: a novel central regulator of peripheral insulin action — Muzumdar RH et al., PLoS One, 2009
- Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives — Karachaliou CE & Livaniou E, Biology (Basel), 2023
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Humanin
Last updated 2026-06-15.